Canada's leading health care & life sciences venture capital firm with a 30-year reputation building companies across North America.
With a 30-year reputation as a leading North American healthcare and life sciences venture capital firm, with offices in Toronto, Montreal, Vancouver and Boston, Lumira Ventures collaborates with and invests in entrepreneurial management teams to build best-in-class, innovation-centric biotherapeutic and medical device companies that are meeting significant unmet needs and creating transformation impact in communities worldwide.Since 1989, Lumira Ventures has invested in over 100 healthcare companies and currently has a portfolio of 30+ active investee companies located in Canada and the United States.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 13, 2022
HistoSonics
|
Convertable Note | $85M | Health Care | — |
Jun 30, 2022
X4 Pharmaceuticals
|
Post-IPO Equity | $55M | Biotechnology | Yes |
Jun 8, 2020
HistoSonics
|
Series C | $40M | Health Care | — |
Apr 8, 2019
HistoSonics
|
Series C | $54.70M | Health Care | Yes |
Jan 8, 2016
Zymeworks
|
Series A | $61.50M | Biotechnology | Yes |